Skip directly to local search Skip directly to A to Z list Skip directly to navigation Skip directly to site content Skip directly to page options
CDC Home

Volume 8, Number 9—September 2002

Research

Characterization of Flagella Produced by Clinical Strains of Stenotrophomonas maltophilia

Doroti de Oliveira-Garcia*†, Monique Dall'Agnol‡, Mónica Rosales‡, Ana C.G.S. Azzuz§, Marina B. Martinez†§, and Jorge A. Girón‡
Author affiliations: *Laboratório Clínico do Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil; †Departamento de Microbiologia do Instituto de Ciências Biomédicas da Universidade de São Paulo, São Paulo, Brazil; ‡Benemerita Universidad Autónoma de Puebla, Puebla, México; §Departamento de Análises Clínicas da Faculdade de Ciências Farmacêuticas da Universidade de São Paulo, São Paulo, Brazil;

Main Article

Figure 4

Reactivity of Stenotrophomonas maltophilia flagellin with different antibodies. Lane 1, SMDP92 strain; lane 2, ATCC 13637. Blots containing whole cells extracts of SMDP92 and ATCC 13637 were reacted with antibodies against SMFliC, flagella of Proteus mirabilis, and anti-FlaA and anti-FlaB of Pseudomonas aeruginosa.

Figure 4. Reactivity of Stenotrophomonas maltophilia flagellin with different antibodies. Lane 1, SMDP92 strain; lane 2, ATCC 13637. Blots containing whole cells extracts of SMDP92 and ATCC 13637 were reacted with antibodies against SMFliC, flagella of Proteus mirabilis, and anti-FlaA and anti-FlaB of Pseudomonas aeruginosa.

Main Article

Top of Page

 

Past Issues

Select a Past Issue:

Art in Science - Selections from Emerging Infectious Diseases
Now available for order



CDC 24/7 – Saving Lives, Protecting People, Saving Money. Learn More About How CDC Works For You…

USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO